PF-04756956

CAS No. 1228934-52-8

PF-04756956( PF04756956 | PF 04756956 )

Catalog No. M10894 CAS No. 1228934-52-8

A potent, selective CCK1 receptor agonist with EC50 of 0.47 nM; elicits no biological response at the CCK2 receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-04756956
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective CCK1 receptor agonist with EC50 of 0.47 nM; elicits no biological response at the CCK2 receptors.
  • Description
    A potent, selective CCK1 receptor agonist with EC50 of 0.47 nM; elicits no biological response at the CCK2 receptors; demonstrates robust weight loss in a diet-induced obese rat model with very low systemic exposure.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PF04756956 | PF 04756956
  • Pathway
    GPCR/G Protein
  • Target
    Cholecystokinin Receptor
  • Recptor
    Cholecystokinin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1228934-52-8
  • Formula Weight
    649.799
  • Molecular Formula
    C40H39N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (4S)-4-((1H-indazol-3-yl)methyl)-6-(2-((R)-2-(3,5-dimethylbenzyl)piperidin-1-yl)-2-oxoethyl)-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5(6H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Desai AJ, et al. J Med Chem. 2015 Dec 24;58(24):9562-77. 2. Cameron KO, et al. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2943-7.
molnova catalog
related products
  • L-365260

    A potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM.

  • A-65186

    A-65186 is an A-type glutamatergic cholecystokinin (CCK) antagonist used to study inflammation and gastrointestinal tract injury.

  • Netazepide

    Netazepide (YF476, Sograzepide)?is a potent, selective and orally active gastrin/CCK-2 antagonist with IC50 of 0.1 nM.